Precipio Announces Commercial Launch of COVID-19 Antibody Test
July 30, 2020 10:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), is announcing its COVID-19 strategy, and its intent to contribute to the battle...
Precipio Reminder of Corporate Update Shareholder Call
May 01, 2019 18:06 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 01, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will host a conference call on Monday, May 6th, 2019 at 5:00pm Eastern Time to review...
Precipio Identifies Manufacturer for its IV-Cell Media
April 09, 2019 09:15 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 09, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced today that it is negotiating a definitive agreement with a manufacturer to...
Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5M
September 21, 2018 09:18 ET
|
Precipio, Inc.
$82,000 monthly debt service to be eliminated with notes convertible into equity at a 65% premium to market NEW HAVEN, Conn., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics Company...
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
August 22, 2018 21:45 ET
|
Precipio, Inc.
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), wishes to remind...
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
August 17, 2018 07:37 ET
|
Precipio, Inc.
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
Precipio Appoints New Board Member to Replace Departing Director
August 09, 2018 07:37 ET
|
Precipio, Inc.
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
June 19, 2018 07:38 ET
|
Precipio, Inc.
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
Precipio Announces Participation Details for Upcoming Shareholder Conference Call
April 26, 2018 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), provides details of its previously announced upcoming shareholder conference call...
Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call
April 17, 2018 07:37 ET
|
Precipio, Inc.
Management to provide strategic business update to shareholders NEW HAVEN, Conn., April 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that...